An Open Label Individual Patient (OLIP)-02 Study of Nusinersen (BIIB058) (clinicaltrials.gov) - Sep 30, 2026 - P3 | N=1 | Not yet recruiting | Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
New P3 trial • Genetic Disorders • Movement Disorders • Muscular Atrophy • Rare Diseases
|